- Home
- PVL vs SRTS Comparison
PVL vs SRTS Comparison
Compare PVL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVL | SRTS |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.1M | 48.9M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PVL | SRTS |
|---|---|---|
| Price | $1.80 | $3.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 49.8K | 21.1K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | ★ 11.72% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $41.11 |
| P/E Ratio | $26.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.58 | $2.66 |
| 52 Week High | $2.01 | $5.49 |
Technical Indicators
Market Signals| Indicator | PVL | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 41.69 |
| Support Level | $1.79 | $2.86 |
| Resistance Level | $1.84 | $3.30 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 33.33 | 10.53 |
Price Performance
Historical ComparisonAbout PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.